These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34514998)

  • 1. CD155: A Key Receptor Playing Diversified Roles.
    Nandi SS; Gohil T; Sawant SA; Lambe UP; Ghosh S; Jana S
    Curr Mol Med; 2022; 22(7):594-607. PubMed ID: 34514998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of inhibitory receptor TIGIT to NK cell education.
    He Y; Peng H; Sun R; Wei H; Ljunggren HG; Yokoyama WM; Tian Z
    J Autoimmun; 2017 Jul; 81():1-12. PubMed ID: 28438433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD155, an onco-immunologic molecule in human tumors.
    Gao J; Zheng Q; Xin N; Wang W; Zhao C
    Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering.
    Stengel KF; Harden-Bowles K; Yu X; Rouge L; Yin J; Comps-Agrar L; Wiesmann C; Bazan JF; Eaton DL; Grogan JL
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5399-404. PubMed ID: 22421438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting PVR (CD155) and its receptors in anti-tumor therapy.
    Kučan Brlić P; Lenac Roviš T; Cinamon G; Tsukerman P; Mandelboim O; Jonjić S
    Cell Mol Immunol; 2019 Jan; 16(1):40-52. PubMed ID: 30275538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus Receptor: More than a simple viral receptor.
    Bowers JR; Readler JM; Sharma P; Excoffon KJDA
    Virus Res; 2017 Oct; 242():1-6. PubMed ID: 28870470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD155 and Its Receptors as Targets for Cancer Therapy.
    Paolini R; Molfetta R
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
    Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
    BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.
    Pignoloni B; Fionda C; Dell'Oste V; Luganini A; Cippitelli M; Zingoni A; Landolfo S; Gribaudo G; Santoni A; Cerboni C
    J Immunol; 2016 Nov; 197(10):4066-4078. PubMed ID: 27733551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.
    Zhand S; Hosseini SM; Tabarraei A; Moradi A; Saeidi M
    J Cancer Res Ther; 2019; 15(1):61-67. PubMed ID: 30880756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
    Li S; Ding J; Wang Y; Wang X; Lv L
    J Gastroenterol Hepatol; 2022 Jan; 37(1):154-163. PubMed ID: 34734434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
    Smazynski J; Hamilton PT; Thornton S; Milne K; Wouters MCA; Webb JR; Nelson BH
    Gynecol Oncol; 2020 Jul; 158(1):167-177. PubMed ID: 32446718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.
    Ma B; Duan X; Zhou Q; Liu J; Yang X; Zhang D; Yang S; Du Y; Li H; Su C
    J Cell Mol Med; 2019 Jul; 23(7):4514-4522. PubMed ID: 31090213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase.
    Inozume T; Yaguchi T; Furuta J; Harada K; Kawakami Y; Shimada S
    J Invest Dermatol; 2016 Jan; 136(1):255-63. PubMed ID: 26763445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
    Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
    J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog.
    Solecki DJ; Gromeier M; Mueller S; Bernhardt G; Wimmer E
    J Biol Chem; 2002 Jul; 277(28):25697-702. PubMed ID: 11983699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma.
    Duan X; Liu J; Cui J; Ma B; Zhou Q; Yang X; Lu Z; Du Y; Su C
    Mol Med Rep; 2019 Oct; 20(4):3773-3781. PubMed ID: 31485637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
    Murakami T; Takasawa A; Takasawa K; Akimoto T; Aoyama T; Magara K; Saito Y; Ota M; Kyuno D; Yamamoto S; Hasegawa T; Saito T; Osanai M
    Cancer Sci; 2021 Feb; 112(2):906-917. PubMed ID: 33185939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD155 in tumor progression and targeted therapy.
    Zhan M; Zhang Z; Zhao X; Zhang Y; Liu T; Lu L; Li XY
    Cancer Lett; 2022 Oct; 545():215830. PubMed ID: 35870689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.